Our CEO, Dennis Schipper, was recently interviewed for the latest edition of LINK Magazine. This edition focuses on diversification, a theme that Demcon has always actively worked on and that remains relevant today. In the interview, Dennis shares his perspective on the importance of diversification, both for Demcon and on a national and international level.

At the Princess Máxima Center for pediatric oncology researchers are growing pediatric tumor organoids to establish the Central Máxima Organoid Biobank (CMOB). This essential work is traditionally time-consuming. To optimize this process, Karin Sanders (Associate group leader Máxima Clevers group & head of Central Máxima Organoid Biobank) and Jarno Drost (Professor at the Princess Máxima Center) will test the RPMotion bioreactor from Orgonex. This innovative technology is designed to grow organoids more efficiently, significantly reducing the manual labor and materials required.

On February 20, Demcon focal had the opportunity to organize a CARLA Hub event to introduce students to industry.

We will attend ZIE – the Zuid Hollands Industrie Event, where technological innovation takes center stage around themes such as energy transition, digitalization, and sustainable industry. We will be present to engage with developments in high tech systems, energy transition, semicon, and related domains.

On April 12 to 16, we will attend SPIE Photonics Europe in Strasbourg, France together with Demcon focal. SPIE Photonics Europe brings the global photonics community together to share the latest advances in optics and photonics. This cross disciplinary event covers technologies ranging from digital optics and optical imaging to quantum technologies, sensing, and metrology.